Pete Corish

Pete Corish has a diverse work experience in the field of biotechnology and life sciences. Pete currently holds the position of VP Business Development Europe at BroadOak Capital Partners. Prior to this, they served as the CEO of Rivela Diagnostics Ltd from April 2022 to October 2023. Pete also held the role of CEO at British Biocell International from September 2007 to December 2009. In addition, Pete has worked in various managerial positions at The BBI Group, Oxonica, Arrow Therapeutics, and Oxford Gene Technology, focusing on areas such as technology acquisition, molecular biology, and biodiagnostics.

Pete Corish obtained a BSc in Genetics from the University of Nottingham in 1988. Pete then pursued a PhD in Molecular Genetics at the University of Cambridge from 1988 to 1991. Afterwards, they conducted post-doctoral research in Molecular Genetics at the University of Leicester from 1992 to 1996. Pete further extended their studies in Cancer Genetics as a post-doctoral researcher at the University of Oxford from 1996 to 1999.